Results 21 to 30 of about 1,783,881 (310)

RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer [PDF]

open access: yes, 2021
Contains fulltext : 244285.pdf (Publisher’s version ) (Open Access)Treatment evaluation in metastatic castration-resistant prostate cancer is challenging.
Irma M. Oving   +33 more
core   +2 more sources

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer

open access: yesBiomarker Research, 2023
Small extracellular vesicles (sEVs) in the blood of cancer patients contain higher amounts of tumor markers than those identified as free-circulating.
Miranda Burdiel   +17 more
doaj   +1 more source

Orthogonal quantification of soluble inducible T-cell costimulator (ICOS) in healthy and diseased human serum

open access: yesJournal of Pharmaceutical Analysis, 2022
Inducible T-cell costimulator (ICOS), a homodimeric protein expressed on the surface of activated T-cells, is being investigated as a potential therapeutic target to treat various cancers.
Kevin McKinski   +5 more
doaj   +1 more source

Systematic evaluation of multiple qPCR platforms, NanoString and miRNA-Seq for microRNA biomarker discovery in human biofluids

open access: yesScientific Reports, 2021
Aberrant miRNA expression has been associated with many diseases, and extracellular miRNAs that circulate in the bloodstream are remarkably stable. Recently, there has been growing interest in identifying cell-free circulating miRNAs that can serve as ...
Lewis Z. Hong   +6 more
doaj   +1 more source

Imaging Biomarkers or Biomarker Imaging? [PDF]

open access: yesPharmaceuticals, 2014
Since biomarker imaging is traditionally understood as imaging of molecular probes, we highly recommend to avoid any confusion with the previously defined term “imaging biomarkers” and, therefore, only use “molecular probe imaging (MPI)” in that context. Molecular probes (MPs) comprise all kinds of molecules administered to an organism which inherently
Markus Mitterhauser, Wolfgang Wadsak
openaire   +3 more sources

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. [PDF]

open access: yes, 2012
New proposed criteria for the clinical diagnosis of Alzheimer's disease increasingly incorporate biomarkers, most of which are normally measured on a continuous scale. Operationalizing such criteria thus requires continuous biomarkers to be dichotomized,
Skillbäck, Tobias,   +10 more
core   +1 more source

The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

open access: yesBMC Endocrine Disorders, 2021
Background Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard.
Anna Thorsø Larsen   +4 more
doaj   +1 more source

Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke

open access: yes, 2023
Intracranial and extracranial large-artery atherosclerosis (LAA) are a main cause of ischemic stroke. Biomarkers may aid in the diagnosis of LAA and help to stratify patients’ risk of stroke.
Ana Catarina Fonseca, Madalena Rosário
core   +1 more source

Biomarkers and Lung Cancer Early Detection: State of the Art

open access: yes, 2021
Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment.
Fabrizio Bianchi   +6 more
core   +1 more source

Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat [PDF]

open access: yes, 2012
Improved biomarkers of acute nephrotoxicity are coveted by the drug development industry, regulatory agencies, and clinicians. In an effort to identify such biomarkers, urinary peptide profiles of rats treated with two different nephrotoxins were ...
Hanig, J.   +23 more
core   +2 more sources

Home - About - Disclaimer - Privacy